US 12,134,776 B2
Development of optimized recombinant expression construct
Seong Hyun Ho, Seoul (KR); and Su Jin Park, Seoul (KR)
Assigned to G&P BIOSCIENCE CO., LTD., Seoul (KR)
Filed by G&P BIOSCIENCE CO., LTD., Seoul (KR)
Filed on Oct. 6, 2021, as Appl. No. 17/495,233.
Prior Publication US 2023/0212603 A1, Jul. 6, 2023
Int. Cl. C12N 15/00 (2006.01); A61K 48/00 (2006.01); C07K 14/005 (2006.01); C07K 14/475 (2006.01); C12N 7/00 (2006.01); C12N 15/85 (2006.01)
CPC C12N 15/85 (2013.01) [A61K 48/0066 (2013.01); C07K 14/005 (2013.01); C07K 14/4753 (2013.01); C12N 7/00 (2013.01); C12N 2710/16143 (2013.01); C12N 2800/107 (2013.01); C12N 2830/34 (2013.01)] 7 Claims
 
1. A recombinant expression construct having the sequence of SEQ ID NO 25.